March 23, 2017 - Wolters Kluwer today reports that it has repurchased 183,100 of its own ordinary shares in the period from March 16, 2017 up to and including March 22, 2017 for €7.0 million and at an average share price of €38.06.
These share repurchases are part of the three-year (2016-2018), up to €600 million buyback program announced on February 24, 2016. The cumulative number of shares repurchased under this three-year program is as follows:
Share Buyback Program 2016-2018
| Period | Cumulative shares repurchased in period | Total consideration (€ million) | Average share price (€) |
| 2017 To Date | 1,630,567 | 58.6 | 35.94 |
| 2016 | 5,826,473 | 199.7 | 34.28 |
| Total | 7,457,040 | 258.3 | 34.64 |
Current share repurchases are made on behalf of Wolters Kluwer by a third party to whom we have given a mandate to buy up to a maximum of €50 million in ordinary shares in the period from March 9, 2017 up to and including May 8, 2017.
Further information is available on our website:
- Download the share buyback transactions excel sheet for detailed individual transaction information.
- Weekly reports on the progress of our share repurchases.
- Overview of share buyback programs.
About Wolters Kluwer
Wolters Kluwer N.V. (AEX: WKL) is a global leader in information services and solutions for professionals in the health, tax and accounting, risk and compliance, finance and legal sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with specialized technology and services.
Wolters Kluwer reported 2016 annual revenues of €4.3 billion. The company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries, and employs 19,000 people worldwide.
Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
For more information about our solutions and organization, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
| Media | Investors/Analysts |
| Annemarije Pikaar | Meg Geldens |
| Corporate Communications | Investor Relations |
| t + 31 172 641 470 | t + 31 172 641 407 |
| [email protected] | [email protected] |
Forward-looking Statements and Other Important Legal Information
This report contains forward-looking statements. These statements may be identified by words such as "expect", "should", "could", "shall" and similar expressions. Wolters Kluwer cautions
that such forward-looking statements are qualified by certain risks and uncertainties that could cause actual results and events to differ materially from what is contemplated by the forward-looking statements. Factors which could cause actual results to differ from these forward-looking statements may include, without limitation, general economic conditions; conditions in the markets in which Wolters Kluwer is engaged; behavior of customers, suppliers, and competitors; technological developments; the implementation and execution of new ICT systems or outsourcing; and legal, tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as risks related to mergers, acquisitions, and divestments. In addition, financial risks such as currency movements, interest rate fluctuations, liquidity, and credit risks could influence future results. The foregoing list of factors should not be construed as exhaustive. Wolters Kluwer disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
This press release contains information which is to be made publicly available under Regulation (EU) 596/2014.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/3237fe3c-fbe1-4538-8f8e-02c2473b2622


NYC Nurses Strike Shuts Down 10 Private Hospitals as 15,000 Demand Safer Staffing and Benefits
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
BlackRock to Cut Around 250 Jobs as CEO Larry Fink Pushes Strategic Shift
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Starlink Internet Remains Active in Iran Despite Nationwide Blackout
Trump Pushes Tech Giants to Absorb AI Data Center Power Costs, Citing Microsoft Changes
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
SK Hynix to Invest $13 Billion in Advanced Chip Packaging Plant as AI Memory Demand Surges
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 



